Posts Tagged ‘Patients’

New Gene Test Provides Approximate Survival Rates for Mesothelioma Patients

New Gene Test Provides Approximate Survival Rates for Mesothelioma Patients

According to a study published in the May 6 Journal of the National Cancer Institute(JNCI), scientists have recently devised a test that can accurately predict which mesothelioma patients have the best chance for survival. The test is also useful for identifying which patients would be the best candidates for surgery, another treatment option for mesothelioma cancer.

The test works by identifying the ratios of four genes present in tissue samples of mesothelioma cancer patients and comparing them with samples of tissue from patients who have survived mesothelioma cancer for an extended period of time. The gene test proved to provide consistent and easily repeatable results across different research campuses. Despite different technicians using different instruments in different laboratories, the test showed a high efficacy rate.

The test was devised by Dr. Raphael Bueno, the Associate Chief in the Division of Thoracic Surgery and Director of the Thoracic Surgery Residency Program at Brigham and Women’s Hospital in Boston, Massachusetts. Previously, predicting a patient’s prognosis was an invasive process; according to Dr. Bueno, major surgery was required to adequately predict the outcome. In the interest of creating a more accessible, less invasive, and accurately informative test, Dr. Bueno and his team looked to preexisting cancer tests. Specifically, the team looked at two gene-based testing methods that have been used in predicting breast cancer recurrence. Though this technology has not been widely used due to heavy logistical requirements, the inspiration provided enough incentive to help Dr. Bueno and his team develop what could be one of the biggest steps forward in accurate mesothelioma diagnosis in recent years.

The study announced in the JNCI was to determine how accurately the test predicted the survival rates of patients. Researchers examined samples of tissue from 120 mesothelioma patients and followed their cases until 2007 or until their death. Using the gene ratio test, researchers categorized the participants in two groups: a good outcome group, and a poor outcome group. On average, the poor outcome group survived 9.5 months; the good outcome group survived 16.8 months, almost double the rate of survival.

Since this test is so revealing about the survival rates of patients, it provides an opportunity for families and individuals to choose the best treatment option for mesothelioma cancer. Patients with good gene ratio test results could be more likely to benefit from surgery, while those in the lower survival rate group seek the best supportive care available.

Mesothelioma is often a very debilitating condition that may require large amounts of physical therapy and treatment options as well as require thousands of dollars in medical costs. It is common for many patients to discuss a mesothelioma lawsuit with an experienced personal injury attorney.

By contacting a mesothelioma lawyer, a patient is increasing their chances of receiving monetary funds as a compensation for the damages endured because of mesothelioma cancer. Additionally, a mesothelioma lawsuit may also result in the reimbursement of expensive medical bills as well as open the door for patients to receive costly medical care that they may have otherwise been able to afford or receive.

For more information on mesothelioma, visit for access to a wide variety or resources, including a mesothelioma attorney, a
mesothelioma lawsuit
, and a mesothelioma lawyer. LegalView also provides access to a construction accident lawyer as well.

Article from

Find More Lawsuit Mesothelioma Articles

Ways for Mesothelioma Patients to Get Organized

Struggling with mesothelioma or another serious illness is an uphill battle, and not being able to find a vital document when you need it is the last thing you want to deal with. One way to prevent this from happening is to organize all of your important paperwork and personal information. Your organizational “system” should allow you and your caregivers to more easily navigate records related to your medical, financial, and legal needs.

Mesothelioma patients can give each other hope

Dr. David Sugarbaker, one of the country’s leading thoracic surgeons, discusses how mesothelioma patients help inspire each other to fight the disease. He is the Director of the International Mesothelioma Program and the Chief of Thoracic Surgery at Harvard’s Brigham and Women’s Hospital in Boston, Mass. Motley Rice LLC co-founder Joe Rice has been representing asbestos clients for decades and discusses mesothelioma treatment options that his clients may want to research.

Dr. David Sugarbaker, one of the country’s leading thoracic surgeons, discusses advances in potential treatment options for mesothelioma patients. He is the Director of the International Mesothelioma Program and the Chief of Thoracic Surgery at Harvard’s Brigham and Women’s Hospital in Boston, Mass. Motley Rice LLC co-founder Joe Rice has been representing asbestos clients for decades and discusses mesothelioma treatment options that his clients may want to research.
Video Rating: 0 / 5

Alimta & Cisplatin Chemotherapy for Mesothelioma Patients

Alimta & Cisplatin Chemotherapy for Mesothelioma Patients

Chemotherapy is often used in conjunction with surgery and/or radiation treatments for cancer. Chemotherapy can be used by itself in cases where the patient is not a candidate for surgery. In 2004, pemetrexed, also commercially known by its brand name Alimta, became the first chemical treatment approved by the Food and Drug Administration specifically in the use of treating mesothelioma patients, a historic event for victims of the asbestos related cancer.

Alimta is only one half of the chemical equation, however. It is used as a combination drug in conjunction with Cisplatin, a platinum based chemical solution for a wide range of cancer patients. Together, the Alimta-Cisplatin combination can be used to prepare candidates for pre-surgery or assist with post-surgery, reducing or outright destroying tumors in the body. For non-surgical candidates, the combination has shown more success in the survival rate of patients than other forms of chemical or radiation treatments.

The Alimta and Cisplatin chemotherapy process is not a cure for malignant mesothelioma, but its usage has been proven to extend the life-span by an average of at least three months. By itself this may not seem to be very helpful, but if a patient is able to become eligible for surgical removal of the cancerous tumor then in that circumstance, the drug will have helped save a life.

Before and after the chemical procedure begins, the patient will be given Vitamin B12 and folic acid. In addition, the day before and after the treatment, a doctor will prescribe a corticosteroid, reducing the chance of an epidermal reaction.

Alimta is taken intravenously for approximately ten minutes every twenty-one days, and thirty minutes later Cisplatin will then be administered. Depending on the patient’s initial response to Cisplatin, the dosage may be reduced or increased. It is important that in attempting to cure the cancer that the liver is not permanently injured.

There are side-effects. This is because chemical therapy is not a pinpoint accurate solution for cancer as surgery is. That is to say, healthy cells will be affected along with the cancerous ones, and this is what causes the side-effects. There is no way to counter this properly, as chemotherapy is meant to kill the cancer cells and so one might think of the healthy ones too close to the cancerous ones as innocent bystander victims in the war against the disease.

The side-effects of Alimta include loss of appetite, nausea, diarrhea, vomiting, mouth sores, skin rash, decrease of red cells which may result in greater risk of infection, decrease of white cells which may lead to anemia, decrease in platelets which may result in bruising and bleeding. The major side effects associated with Cisplatin include kidney damage, nerve damage, hearing loss, and hair loss.

Allergic reactions to Alimta are possible, and patients and those caring for them should be aware of the symptoms if a change in chemical treatment is necessary. Symptoms of an allergic reaction include swelling of the face, lips, tongue, or throat, fever greater than 100.4 Fahrenheit, or hives.

Donald Nye is a respected researcher and writer that has been writing about asbestos-related health issues, such as mesothelioma, since 1987.

Article from

Legal Help and Support for Mesothelioma Patients – Video

Has your doctor diagnosed you with Mesothelioma? We are the law firm that helps Mesothelioma patients. Watch this video- We have been helping Asbestos victims since 1974. We have all the information you need to make an informed decision about legal counsel. Learn about your treatment options, such as surgery, Chemotherapy or clinical trials, all at our website. Call us today to discuss your case at 877.622.5246 or visit
Video Rating: 0 / 5 Want to know about Mesothelioma and smoking? Kazan Law has decades of experience in handling Mesothelioma Asbestos cases. Mesothelioma patients deserve an experienced Asbestos lawyer – weve acted in Mesothelioma class action suits, getting compensation for all members of…
Video Rating: 0 / 5

When need chemotherapy for mesothelioma patients

When need chemotherapy for mesothelioma patients

The needs of chemotherapy will be decided by your doctors. Several factors involve with this treatment such as stage of the cancer, types of cancer, types of drugs you are taking, age of the tumor etc. The doctors will also think about the goal of the chemotherapy is stop the growth of the tumor or completely erase the tumor.

Generally, chemotherapy treatment is administered in a cyclic manner which is defined as a period of treatment followed by a period of rest. The purpose of this cycle is to allow the cancer cells to be attacked by the drugs, and then allows the body’s normal cells time to recover.

Chemotherapy treatment should be a supportive effort between you and your doctor. The communication that takes place is important to your health. It will help you feel better along with address any potential problems with improper communication.

For mesothelioma patients, mesothelioma cancer can be treated by the use of anti cancer drug therapies. These anti cancer drugs act by inhibiting tumor growth through the blocking of cell division and multiplication. This form of action also unfortunately affects other hurriedly replicating cells in the body, cells of the hair and the lining of the intestine are particularly vulnerable, thus leading to the common side effects of anti cancer drugs like hair loss and nausea.

There are various side effect could with mesothelioma chemotherapy treatment, these are
-Fever of, or greater than 101 degrees
-Diarrhea or constipation
-Tingling or numbness in the fingers or toes
-Ringing in the ear
s -Bruises or rashes
-Sores in the mouth or throat
-Reduced white blood cell count {neutropenia} making you more prone to infections. For this reason your full blood count should be monitored closely.

For more information about mesothelioma chemotherapy and chemotherapy treatment please visit

Jeff is an experienced author, he has been writing articles for a reliable New Mesothelioma Treatment for more than 4 years. If you need any information or help regarding mesothelioma treatment please visit our website

Article from